Skip to content

A study to compare Dapoxetine, Yoga and a combination of Dapoxetine with Yoga for treatment of sexual problem of early ejaculation

A Randomised Control trial comparing Yoga, Dapoxetine and Dapoxetine with Yoga in Premature Ejaculation

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025878
Enrollment
90
Registered
2020-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F524- Premature ejaculation

Interventions

Intervention1: Yoga: All Yoga Practices to be used in the current trial are based on hatha-yoga and chosen from established yogic literature like Light on Yoga, Gherand Samhita and Asana Pranayama Mud

Sponsors

AIIMS Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) Subjects diagnosed with Premature Ejaculation as per ISSM (International Society of Sexual Medicine) and ICD-10 (2) Subjects consenting to be sexually active (intravaginal intercourse) during the study period (3) Subjects providing written informed consent

Exclusion criteria

Exclusion criteria: 1. Subjects who have used investigational drug (Dapoxetine) within the past 1 month 2. Subjects not having consistent sexual partner in heterosexual relationship 3. Subjects having a medical condition(s) which could affect sexual functioning 4. Subjects on psychotropics medication or other drug which are known to either affect sexual functioning or cause drug interaction with the investigational drug (Dapoxetine) 5. Subjects not having any co-morbid psychiatric condition which may affect sexual functioning 6. Subjects using the substance known to affect sexual functioning

Design outcomes

Primary

MeasureTime frame
IELT (Intravaginal Ejaculatory Latency Time)Timepoint: one time during the preparation phase (within the first 2 weeks of the start of the study) and then 3 times at 4 weekly intervals during the intervention phase ( at 6 week, 10 week, 14 weeks)

Secondary

MeasureTime frame
Premature ejaculation diagnostic tool (PEDT) ScoreTimepoint: one time during the preparation phase (within the first 2 weeks of the start of the study) and then 3 times at 4 weekly intervals during the intervention phase ( at 6 week, 10 week, 14 weeks)

Countries

India

Contacts

Public ContactJitendra Rohilla

All India Institute of Medical Sciences

jiten.sms@gmail.com9414531839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026